Oman

Oman

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.5 (2.11 - 2.90) 2019 Modelled IHME
2.55 (2.22 - 2.99) 2018 Modelled IHME
2.57 (2.20 - 3.03) 2017 Modelled IHME
2.53 (2.16 - 2.99) 2016 Modelled IHME
2.49 (2.07 - 2.96) 2015 Modelled IHME
2.5 (2.09 - 2.98) 2014 Modelled IHME
2.55 (2.13 - 3.02) 2013 Modelled IHME
2.6 (2.18 - 3.06) 2012 Modelled IHME
2.66 (2.23 - 3.14) 2011 Modelled IHME
2.71 (2.27 - 3.18) 2010 Modelled IHME
2.74 (2.33 - 3.20) 2009 Modelled IHME
2.76 (2.36 - 3.18) 2008 Modelled IHME
2.79 (2.39 - 3.20) 2007 Modelled IHME
2.82 (2.43 - 3.23) 2006 Modelled IHME
2.86 (2.45 - 3.30) 2005 Modelled IHME
2.93 (2.55 - 3.35) 2004 Modelled IHME
3.04 (2.63 - 3.47) 2003 Modelled IHME
3.17 (2.72 - 3.64) 2002 Modelled IHME
3.31 (2.81 - 3.83) 2001 Modelled IHME
3.44 (2.91 - 4.02) 2000 Modelled IHME
3.58 (3.02 - 4.14) 1999 Modelled IHME
3.73 (3.15 - 4.28) 1998 Modelled IHME
3.88 (3.29 - 4.47) 1997 Modelled IHME
4.05 (3.43 - 4.66) 1996 Modelled IHME
4.22 (3.55 - 4.89) 1995 Modelled IHME
4.42 (3.77 - 5.08) 1994 Modelled IHME
4.63 (3.98 - 5.29) 1993 Modelled IHME
4.85 (4.18 - 5.54) 1992 Modelled IHME
5.09 (4.38 - 5.85) 1991 Modelled IHME
5.34 (4.58 - 6.21) 1990 Modelled IHME
3.2 (2.23 - 4.48) 2015 Modelled WHO
2.5 (2.10 - 2.90) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.09 (0.07 - 0.11) 2019 Modelled IHME
0.09 (0.07 - 0.11) 2018 Modelled IHME
0.09 (0.07 - 0.12) 2017 Modelled IHME
0.09 (0.07 - 0.12) 2016 Modelled IHME
0.09 (0.07 - 0.12) 2015 Modelled IHME
0.09 (0.07 - 0.12) 2014 Modelled IHME
0.09 (0.07 - 0.12) 2013 Modelled IHME
0.09 (0.07 - 0.12) 2012 Modelled IHME
0.09 (0.07 - 0.11) 2011 Modelled IHME
0.09 (0.07 - 0.11) 2010 Modelled IHME
0.09 (0.07 - 0.11) 2009 Modelled IHME
0.08 (0.07 - 0.11) 2008 Modelled IHME
0.08 (0.06 - 0.11) 2007 Modelled IHME
0.08 (0.06 - 0.11) 2006 Modelled IHME
0.08 (0.06 - 0.11) 2005 Modelled IHME
0.08 (0.06 - 0.11) 2004 Modelled IHME
0.08 (0.06 - 0.11) 2003 Modelled IHME
0.08 (0.07 - 0.11) 2002 Modelled IHME
0.09 (0.07 - 0.11) 2001 Modelled IHME
0.09 (0.07 - 0.12) 2000 Modelled IHME
0.09 (0.07 - 0.12) 1999 Modelled IHME
0.1 (0.08 - 0.13) 1998 Modelled IHME
0.11 (0.08 - 0.14) 1997 Modelled IHME
0.12 (0.09 - 0.15) 1996 Modelled IHME
0.13 (0.10 - 0.17) 1995 Modelled IHME
0.14 (0.11 - 0.18) 1994 Modelled IHME
0.16 (0.12 - 0.20) 1993 Modelled IHME
0.18 (0.14 - 0.22) 1992 Modelled IHME
0.2 (0.15 - 0.25) 1991 Modelled IHME
0.22 (0.17 - 0.28) 1990 Modelled IHME
0.44 (0.26 - 0.71) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
103,807 (89,003 - 120,617) 1990 Modelled IHME
101,507 (87,368 - 116,717) 1991 Modelled IHME
99,684 (85,913 - 113,737) 1992 Modelled IHME
97,494 (83,876 - 111,473) 1993 Modelled IHME
94,331 (80,594 - 108,572) 1994 Modelled IHME
91,082 (76,620 - 105,350) 1995 Modelled IHME
88,835 (75,403 - 102,317) 1996 Modelled IHME
87,309 (74,080 - 100,454) 1997 Modelled IHME
85,331 (72,237 - 98,086) 1998 Modelled IHME
82,252 (69,413 - 95,191) 1999 Modelled IHME
79,211 (66,866 - 92,492) 2000 Modelled IHME
77,219 (65,659 - 89,378) 2001 Modelled IHME
75,774 (65,178 - 87,146) 2002 Modelled IHME
73,602 (63,807 - 84,104) 2003 Modelled IHME
70,439 (61,220 - 80,483) 2004 Modelled IHME
68,388 (58,673 - 78,808) 2005 Modelled IHME
68,917 (59,363 - 78,997) 2006 Modelled IHME
70,936 (60,852 - 81,367) 2007 Modelled IHME
72,474 (61,910 - 83,405) 2008 Modelled IHME
73,590 (62,525 - 85,941) 2009 Modelled IHME
76,805 (64,285 - 90,160) 2010 Modelled IHME
84,428 (70,869 - 99,556) 2011 Modelled IHME
93,728 (78,613 - 110,342) 2012 Modelled IHME
97,867 (81,832 - 115,864) 2013 Modelled IHME
99,234 (82,814 - 117,920) 2014 Modelled IHME
102,628 (85,269 - 122,252) 2015 Modelled IHME
110,453 (94,318 - 130,702) 2016 Modelled IHME
115,712 (99,255 - 136,498) 2017 Modelled IHME
115,424 (100,308 - 135,374) 2018 Modelled IHME
114,380 (96,850 - 132,931) 2019 Modelled IHME
111,000 (95,000 - 127,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.82 (1.27 - 2.55) 2019 Modelled IHME
1.87 (1.31 - 2.60) 2018 Modelled IHME
1.93 (1.38 - 2.62) 2017 Modelled IHME
1.96 (1.42 - 2.63) 2016 Modelled IHME
2.01 (1.48 - 2.65) 2015 Modelled IHME
2.06 (1.52 - 2.73) 2014 Modelled IHME
2.16 (1.63 - 2.83) 2013 Modelled IHME
2.28 (1.74 - 2.93) 2012 Modelled IHME
2.39 (1.86 - 3.01) 2011 Modelled IHME
2.44 (1.93 - 3.06) 2010 Modelled IHME
2.54 (2 - 3.16) 2009 Modelled IHME
2.47 (1.96 - 3.09) 2008 Modelled IHME
2.41 (1.89 - 3.01) 2007 Modelled IHME
2.28 (1.80 - 2.84) 2006 Modelled IHME
2.17 (1.71 - 2.69) 2005 Modelled IHME
2.1 (1.66 - 2.63) 2004 Modelled IHME
2.11 (1.64 - 2.69) 2003 Modelled IHME
2.12 (1.62 - 2.74) 2002 Modelled IHME
2.1 (1.58 - 2.74) 2001 Modelled IHME
2.04 (1.51 - 2.67) 2000 Modelled IHME
2.12 (1.55 - 2.80) 1999 Modelled IHME
2.39 (1.74 - 3.18) 1998 Modelled IHME
2.7 (1.97 - 3.63) 1997 Modelled IHME
2.93 (2.13 - 3.96) 1996 Modelled IHME
2.98 (2.17 - 4.04) 1995 Modelled IHME
2.99 (2.15 - 4.05) 1994 Modelled IHME
3.01 (2.16 - 4.09) 1993 Modelled IHME
3.09 (2.17 - 4.25) 1992 Modelled IHME
3.14 (2.16 - 4.41) 1991 Modelled IHME
3.17 (2.17 - 4.47) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
84 (58 - 117) 2019 Modelled IHME
84 (59 - 118) 2018 Modelled IHME
87 (62 - 118) 2017 Modelled IHME
86 (62 - 115) 2016 Modelled IHME
83 (61 - 109) 2015 Modelled IHME
82 (60 - 108) 2014 Modelled IHME
83 (62 - 109) 2013 Modelled IHME
82 (63 - 105) 2012 Modelled IHME
76 (59 - 96) 2011 Modelled IHME
69 (55 - 87) 2010 Modelled IHME
68 (54 - 85) 2009 Modelled IHME
65 (51 - 81) 2008 Modelled IHME
61 (48 - 76) 2007 Modelled IHME
56 (44 - 69) 2006 Modelled IHME
52 (41 - 64) 2005 Modelled IHME
51 (40 - 63) 2004 Modelled IHME
51 (40 - 65) 2003 Modelled IHME
51 (39 - 66) 2002 Modelled IHME
49 (37 - 64) 2001 Modelled IHME
47 (35 - 61) 2000 Modelled IHME
49 (36 - 64) 1999 Modelled IHME
55 (40 - 73) 1998 Modelled IHME
61 (44 - 82) 1997 Modelled IHME
64 (47 - 87) 1996 Modelled IHME
64 (47 - 87) 1995 Modelled IHME
64 (46 - 87) 1994 Modelled IHME
63 (46 - 86) 1993 Modelled IHME
64 (45 - 87) 1992 Modelled IHME
63 (43 - 88) 1991 Modelled IHME
62 (42 - 87) 1990 Modelled IHME
153 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
43 (34 - 53) 2019 Modelled IHME
43 (34 - 53) 2018 Modelled IHME
43 (34 - 54) 2017 Modelled IHME
43 (34 - 53) 2016 Modelled IHME
43 (34 - 53) 2015 Modelled IHME
43 (34 - 53) 2014 Modelled IHME
43 (34 - 53) 2013 Modelled IHME
43 (34 - 53) 2012 Modelled IHME
42 (34 - 52) 2011 Modelled IHME
41 (33 - 51) 2010 Modelled IHME
41 (33 - 51) 2009 Modelled IHME
41 (33 - 51) 2008 Modelled IHME
41 (33 - 51) 2007 Modelled IHME
41 (32 - 51) 2006 Modelled IHME
41 (32 - 51) 2005 Modelled IHME
41 (33 - 51) 2004 Modelled IHME
41 (33 - 51) 2003 Modelled IHME
42 (33 - 52) 2002 Modelled IHME
42 (33 - 52) 2001 Modelled IHME
41 (33 - 51) 2000 Modelled IHME
42 (33 - 52) 1999 Modelled IHME
42 (34 - 52) 1998 Modelled IHME
43 (35 - 53) 1997 Modelled IHME
44 (35 - 54) 1996 Modelled IHME
44 (35 - 54) 1995 Modelled IHME
43 (35 - 54) 1994 Modelled IHME
43 (35 - 53) 1993 Modelled IHME
43 (35 - 53) 1992 Modelled IHME
43 (34 - 53) 1991 Modelled IHME
43 (34 - 53) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
97 2002 Survey/reported WHO/UNICEF
97 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
98 2013 Survey/reported WHO/UNICEF
98 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
99 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
99 1999 Survey/reported WHO/UNICEF
99 1998 Survey/reported WHO/UNICEF
99 1997 Survey/reported WHO/UNICEF
99 1996 Survey/reported WHO/UNICEF
99 1995 Survey/reported WHO/UNICEF
99 1994 Survey/reported WHO/UNICEF
96 1993 Survey/reported WHO/UNICEF
99 1992 Survey/reported WHO/UNICEF
94 1991 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2014 Survey/reported Oman National AIDS Programme, 2014.
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2014 Survey/reported Oman National AIDS Programme, 2014
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.37 (1.10 - 1.70) 2019 Modelled IHME
1.37 (1.10 - 1.70) 2018 Modelled IHME
1.37 (1.10 - 1.72) 2017 Modelled IHME
1.36 (1.09 - 1.69) 2016 Modelled IHME
1.36 (1.09 - 1.69) 2015 Modelled IHME
1.37 (1.10 - 1.70) 2014 Modelled IHME
1.37 (1.11 - 1.70) 2013 Modelled IHME
1.38 (1.11 - 1.71) 2012 Modelled IHME
1.39 (1.12 - 1.73) 2011 Modelled IHME
1.39 (1.13 - 1.74) 2010 Modelled IHME
1.4 (1.13 - 1.74) 2009 Modelled IHME
1.4 (1.13 - 1.74) 2008 Modelled IHME
1.4 (1.14 - 1.75) 2007 Modelled IHME
1.4 (1.14 - 1.75) 2006 Modelled IHME
1.4 (1.14 - 1.75) 2005 Modelled IHME
1.4 (1.14 - 1.74) 2004 Modelled IHME
1.4 (1.13 - 1.73) 2003 Modelled IHME
1.39 (1.12 - 1.73) 2002 Modelled IHME
1.39 (1.12 - 1.73) 2001 Modelled IHME
1.39 (1.12 - 1.73) 2000 Modelled IHME
1.39 (1.12 - 1.73) 1999 Modelled IHME
1.4 (1.12 - 1.74) 1998 Modelled IHME
1.4 (1.12 - 1.74) 1997 Modelled IHME
1.41 (1.14 - 1.75) 1996 Modelled IHME
1.42 (1.14 - 1.76) 1995 Modelled IHME
1.43 (1.16 - 1.77) 1994 Modelled IHME
1.45 (1.17 - 1.79) 1993 Modelled IHME
1.47 (1.17 - 1.81) 1992 Modelled IHME
1.49 (1.19 - 1.85) 1991 Modelled IHME
1.51 (1.21 - 1.88) 1990 Modelled IHME
0.4 (0.30 - 0.40) 2015 Modelled Blach et al, 2017
Showing out of
Show more

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
29,371 (23,520 - 36,589) 1990 Modelled IHME
29,680 (23,745 - 36,868) 1991 Modelled IHME
30,147 (24,140 - 37,241) 1992 Modelled IHME
30,527 (24,577 - 37,715) 1993 Modelled IHME
30,609 (24,745 - 37,774) 1994 Modelled IHME
30,656 (24,603 - 37,868) 1995 Modelled IHME
31,009 (24,927 - 38,349) 1996 Modelled IHME
31,585 (25,306 - 39,105) 1997 Modelled IHME
31,991 (25,730 - 39,836) 1998 Modelled IHME
31,977 (25,711 - 39,828) 1999 Modelled IHME
31,980 (25,693 - 39,846) 2000 Modelled IHME
32,508 (26,160 - 40,455) 2001 Modelled IHME
33,379 (26,818 - 41,462) 2002 Modelled IHME
33,885 (27,348 - 41,982) 2003 Modelled IHME
33,671 (27,276 - 41,889) 2004 Modelled IHME
33,524 (27,216 - 41,886) 2005 Modelled IHME
34,266 (27,767 - 42,810) 2006 Modelled IHME
35,621 (28,914 - 44,502) 2007 Modelled IHME
36,672 (29,681 - 45,709) 2008 Modelled IHME
37,517 (30,347 - 46,819) 2009 Modelled IHME
39,532 (31,967 - 49,373) 2010 Modelled IHME
44,054 (35,633 - 54,885) 2011 Modelled IHME
49,713 (40,111 - 61,658) 2012 Modelled IHME
52,740 (42,490 - 65,497) 2013 Modelled IHME
54,121 (43,636 - 67,180) 2014 Modelled IHME
56,214 (45,173 - 69,761) 2015 Modelled IHME
59,623 (47,865 - 73,817) 2016 Modelled IHME
61,602 (49,454 - 77,475) 2017 Modelled IHME
61,890 (49,652 - 77,203) 2018 Modelled IHME
62,666 (50,402 - 78,024) 2019 Modelled IHME
16,000 (12,000 - 18,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.33 (2.39 - 4.79) 2019 Modelled IHME
3.4 (2.48 - 4.79) 2018 Modelled IHME
3.52 (2.65 - 4.90) 2017 Modelled IHME
3.58 (2.73 - 4.89) 2016 Modelled IHME
3.69 (2.83 - 4.93) 2015 Modelled IHME
3.8 (2.93 - 5.02) 2014 Modelled IHME
3.99 (3.09 - 5.19) 2013 Modelled IHME
4.23 (3.35 - 5.36) 2012 Modelled IHME
4.48 (3.67 - 5.44) 2011 Modelled IHME
4.66 (3.83 - 5.53) 2010 Modelled IHME
4.85 (4.01 - 5.75) 2009 Modelled IHME
4.67 (3.86 - 5.57) 2008 Modelled IHME
4.51 (3.75 - 5.38) 2007 Modelled IHME
4.29 (3.59 - 5.13) 2006 Modelled IHME
4.15 (3.45 - 4.99) 2005 Modelled IHME
4.03 (3.31 - 4.87) 2004 Modelled IHME
4.05 (3.29 - 5.01) 2003 Modelled IHME
4.08 (3.29 - 5.07) 2002 Modelled IHME
4.06 (3.22 - 5.11) 2001 Modelled IHME
3.96 (3.09 - 5.02) 2000 Modelled IHME
3.82 (2.94 - 4.91) 1999 Modelled IHME
3.71 (2.80 - 4.84) 1998 Modelled IHME
3.61 (2.70 - 4.79) 1997 Modelled IHME
3.52 (2.61 - 4.70) 1996 Modelled IHME
3.44 (2.53 - 4.60) 1995 Modelled IHME
3.44 (2.52 - 4.60) 1994 Modelled IHME
3.46 (2.50 - 4.66) 1993 Modelled IHME
3.56 (2.53 - 4.89) 1992 Modelled IHME
3.65 (2.56 - 5.01) 1991 Modelled IHME
3.72 (2.55 - 5.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
153 (110 - 219) 2019 Modelled IHME
154 (112 - 217) 2018 Modelled IHME
159 (119 - 221) 2017 Modelled IHME
157 (119 - 214) 2016 Modelled IHME
152 (117 - 203) 2015 Modelled IHME
150 (116 - 199) 2014 Modelled IHME
153 (119 - 199) 2013 Modelled IHME
152 (121 - 193) 2012 Modelled IHME
142 (116 - 173) 2011 Modelled IHME
132 (109 - 157) 2010 Modelled IHME
130 (108 - 155) 2009 Modelled IHME
123 (101 - 146) 2008 Modelled IHME
115 (95 - 137) 2007 Modelled IHME
105 (88 - 125) 2006 Modelled IHME
99 (83 - 119) 2005 Modelled IHME
97 (79 - 117) 2004 Modelled IHME
98 (80 - 121) 2003 Modelled IHME
98 (79 - 121) 2002 Modelled IHME
95 (75 - 119) 2001 Modelled IHME
91 (71 - 116) 2000 Modelled IHME
88 (68 - 113) 1999 Modelled IHME
85 (64 - 111) 1998 Modelled IHME
81 (61 - 108) 1997 Modelled IHME
77 (57 - 103) 1996 Modelled IHME
74 (55 - 99) 1995 Modelled IHME
73 (54 - 98) 1994 Modelled IHME
73 (53 - 98) 1993 Modelled IHME
73 (52 - 100) 1992 Modelled IHME
73 (51 - 100) 1991 Modelled IHME
72 (50 - 101) 1990 Modelled IHME
61 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
28 (20 - 37) 2019 Modelled IHME
28 (20 - 37) 2018 Modelled IHME
28 (20 - 38) 2017 Modelled IHME
28 (20 - 38) 2016 Modelled IHME
29 (20 - 38) 2015 Modelled IHME
29 (20 - 38) 2014 Modelled IHME
29 (20 - 38) 2013 Modelled IHME
29 (21 - 38) 2012 Modelled IHME
30 (21 - 38) 2011 Modelled IHME
30 (22 - 39) 2010 Modelled IHME
31 (22 - 40) 2009 Modelled IHME
31 (22 - 40) 2008 Modelled IHME
31 (22 - 40) 2007 Modelled IHME
31 (22 - 40) 2006 Modelled IHME
32 (23 - 41) 2005 Modelled IHME
32 (23 - 40) 2004 Modelled IHME
31 (22 - 40) 2003 Modelled IHME
31 (22 - 40) 2002 Modelled IHME
31 (22 - 40) 2001 Modelled IHME
32 (23 - 40) 2000 Modelled IHME
31 (22 - 40) 1999 Modelled IHME
31 (22 - 40) 1998 Modelled IHME
31 (22 - 39) 1997 Modelled IHME
30 (21 - 39) 1996 Modelled IHME
31 (21 - 40) 1995 Modelled IHME
31 (22 - 40) 1994 Modelled IHME
31 (22 - 40) 1993 Modelled IHME
31 (23 - 40) 1992 Modelled IHME
32 (23 - 41) 1991 Modelled IHME
32 (23 - 41) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2014 Survey/reported Oman National AIDS Programme, 2014.
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2014 Survey/reported Oman National AIDS Programme, 2014
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
84
2019
(58 - 117)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
153
2019
(110 - 219)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
99 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2014
(0 - 0)
Oman National AIDS Programme, 2014.
Eligible for HBV generic medicines
Eligible for HCV generic medicines